We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$6.14B
1-Year Est. Return
42.05%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.19B
AUM Growth
-$467M
(-10%)
Cap. Flow
-$654M
Cap. Flow
% of AUM
-15.61%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
140
New
55
Increased
21
Reduced
30
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$61.5M |
| 2 |
Ulta Beauty
ULTA
|
+$58.8M |
| 3 |
AGN
Allergan plc
AGN
|
+$51.8M |
| 4 |
EA
Electronic Arts
EA
|
+$51.1M |
| 5 |
HCA Healthcare
HCA
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$123M |
| 2 |
Regions Financial
RF
|
+$105M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$105M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$84M |
| 5 |
CMA
Comerica
CMA
|
+$77.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.31% |
| 2 | Consumer Discretionary | 16.64% |
| 3 | Financials | 14.59% |
| 4 | Technology | 9.5% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aramark
ARMK
$15.1B
| $233M | 5.57% |
9,662,590
+27,015
| +0.3% | +$650K |
|
|
AMJ
2
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $159M | 3.8% |
5,000,000
| – | – |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $150M | 3.59% |
650,295
+224,515
| +53% | +$51.8M |
|
4
Constellation Brands
STZ
$22B
| $140M | 3.35% |
847,879
-374,883
| -31% | -$58.7M |
|
|
5
Biogen
BIIB
$33.2B
| $128M | 3.07% |
530,927
+233,420
| +78% | +$61.5M |
|
6
Air Products & Chemicals
APD
$67.7B
| $106M | 2.53% |
807,075
-39,348
| -5% | -$5.24M |
|
|
CLGX
7
DELISTED
Corelogic, Inc.
CLGX
| $94M | 2.24% |
2,443,689
-54,569
| -2% | -$1.99M |
|
8
Valero Energy
VLO
$107B
| $93.4M | 2.23% |
1,831,866
+522,000
| +40% | +$29.5M |
|
|
EVHC
9
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $91.4M | 2.18% |
1,202,666
-153,869
| -11% | -$10.9M |
|
10
UnitedHealth
UNH
$360B
| $87.5M | 2.09% |
619,943
-26,486
| -4% | -$3.53M |
|
11
HDFC Bank
HDB
$120B
| $85.8M | 2.05% |
5,169,592
-189,568
| -4% | -$3.02M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $82.9M | 1.98% |
679,170
-271,193
| -29% | -$31.1M |
|
|
EMC
13
DELISTED
EMC CORPORATION
EMC
| $76.5M | 1.83% |
2,816,665
-147,900
| -5% | -$4M |
|
|
AGN
14
PUT
DELISTED
Allergan plc
AGN
| $75.1M | 1.79% |
+325,000
| New | +$74.9M |
|
15
Labcorp
LH
$26.9B
| $74M | 1.77% |
661,186
+3,520
| +0.5% | +$379K |
|
16
Allstate
ALL
$66.5B
| $74M | 1.77% |
1,057,607
+74,000
| +8% | +$4.96M |
|
17
DigitalBridge
DBRG
$2.99B
| $73M | 1.74% |
1,788,532
+191,125
| +12% | +$9.09M |
|
18
Amazon
AMZN
$2.79T
| $72.6M | 1.73% |
2,027,900
+23,340
| +1% | +$789K |
|
19
Methanex
MEOH
$4.59B
| $67M | 1.6% |
2,302,158
-437,242
| -16% | -$14M |
|
|
SC
20
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $66.1M | 1.58% |
6,397,120
+302,171
| +5% | +$3.51M |
|
|
21
Ulta Beauty
ULTA
$23.8B
| $65.8M | 1.57% |
+270,205
| New | +$58.8M |
|
22
Expedia Group
EXPE
$36.4B
| $65.8M | 1.57% |
618,703
-121,209
| -16% | -$13.2M |
|
23
McKesson
MCK
$107B
| $65.5M | 1.56% |
350,767
+47,995
| +16% | +$8.42M |
|
24
Ferrari
RACE
$73.5B
| $65.2M | 1.56% |
1,591,744
+268,844
| +20% | +$11.4M |
|
|
KATE
25
DELISTED
Kate Spade & Company
KATE
| $58.6M | 1.4% |
2,843,657
-896,343
| -24% | -$20.4M |
|
Similar funds
MF
LP
SLI
MSU
EQF
PAMP
WCM
MOS
Samlyn Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Samlyn Capital held 140 positions worth $4.19B, down 10% from $4.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Samlyn Capital withdrew a net $654M in Q2 2016, closing 30 positions and reducing 30 holdings. Its most notable exit was Regions Financial, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Samlyn Capital opened a new position in Ulta Beauty worth $65.8M.
- Samlyn Capital's largest Q2 2016 buy was Ulta Beauty: 270,205 shares worth $65.8M.
- Samlyn Capital added most to Biogen in Q2 2016, an estimated $61.5M increase.
- Samlyn Capital's biggest Q2 2016 reduction was KeyCorp, cutting an estimated $123M.
- Samlyn Capital fully exited Regions Financial in Q2 2016, selling an estimated $105M.
- Samlyn Capital's ten largest holdings make up 31% of its $4.19B portfolio in Q2 2016.
- Samlyn Capital opened 55 new positions and closed 30 in Q2 2016.
- Samlyn Capital's portfolio value fell 10% quarter-over-quarter to $4.19B.
Based on Samlyn Capital's 13F filing for Q2 2016, filed 15 Aug 2016.